Skip to main content

Table 3 Results of Cox regression analysis of pancreatic ductal adenocarcinoma patients (n = 91)

From: Elevated urinary levels of urokinase-type plasminogen activator receptor (uPAR) in pancreatic ductal adenocarcinoma identify a clinically high-risk group

Variable

Odds Ratio

95% CI

p

Gender = female

1.85

1.16 - 2.96

0.01

Stage = I, II

1

-

-

Stage = III

2.65

1.45 - 4.87

0.0017

Stage = IV

4.61

2.42 - 8.76

< 0.0001

High (> 9.1 ng/mg) suPAR/creatinine

2.10

1.31 - 3.36

0.0023

Age

1.02

1.00-1.04

0.067